A powerful cooperative interaction between a fusogenic peptide and lipofectamine for the enhancement of receptor-targeted, non-viral gene delivery via integrin receptors

This publication has 15 references indexed in Scilit:

• Gene transfer mediated by fusion protein hemagglutinin reconstituted in cationic lipid vesicles
  Gene Therapy, 1999
• Lipid-Mediated Enhancement of Transfection by a Nonviral Integrin-Targeting Vector
  Human Gene Therapy, 1998
• Cationic Liposomes Enhance Adenovirus Entry via a Pathway Independent of the Fiber Receptor andα_v-Integrins
  Human Gene Therapy, 1998
• The effect of cationic liposome pretreatment and centrifugation on retrovirus-mediated gene transfer
  Gene Therapy, 1997
• Receptor Ligand-Facilitated Gene Transfer: Enhancement of Liposome-Mediated Gene Transfer and Expression by Transferrin
  Human Gene Therapy, 1996
• Non-viral gene therapy
  Current Opinion in Biotechnology, 1994
• Specific gene transfer mediated by lactosylated poly-L-lysine into hepatoma cells
  Nucleic Acids Research, 1993
• Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle.
  Proceedings of the National Academy of Sciences, 1992
• Cationic liposomes enhance targeted delivery and expression of exogenous DNA mediated by N-terminal modified poly(l-lysine)-antibody conjugate in mouse lung endothelial cells
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1992
• ACIDIFICATION OF THE ENDOCYTIC AND EXOCYTIC PATHWAYS
  Annual Review of Biochemistry, 1986